For more than a year, Diane Hunter, now 72, had been experiencing vague symptoms—pain in her spine and hips, nausea, ...
Support for first and only high-risk smouldering multiple myeloma treatment came from positive phase 3 trial results ...
MedPage Today on MSN
For Your Patients: Understanding Relapse and What It Means for Your Multiple Myeloma
Multiple myeloma can relapse two or more times, and tends to become more aggressive and more treatment-resistant with each ...
The FDA has approved daratumumab and hyaluronidase-fihj monotherapy as treatment for adults with high-risk smoldering ...
Dr. Joseph Mikhael discusses the overlooked symptoms of multiple myeloma in honor of Myeloma Awareness Month. March is Myeloma Awareness Month, a time to recognize the subtle but serious symptoms of ...
MedPage Today on MSN
Unusual Adverse Events After Treatment for Relapsed/Refractory Multiple Myeloma
The treatment of relapsed/refractory multiple myeloma dramatically changed in recent years with the emergence of therapies ...
Kimberly Alexander's caregiving experience revealed a lack of awareness and support for multiple myeloma, especially in the ...
5d
FDA Clears Johnson & Johnson's Darzalex Faspro, Enabling Early Intervention In Myeloma Progression
The FDA approves Johnson & Johnson's Darzalex Faspro for high-risk smoldering multiple myeloma and Caplyta as an add-on ...
A Stakeholder Interchange convened in Los Angeles, California, by The American Journal of Managed Care explores the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback